Reproductive endocrinology

The effects of time‐restricted eating alone or in combination with probiotic supplementation in comparison with a calorie‐restricted diet on endocrine and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial

Diabetes Obes MetabPublished Randomised controlled trial

Authors' conclusion

The eTRE alone or eTRE plus probiotics did not result in significantly greater weight loss or improvements in metabolic, menstrual and gonadal variables compared with the standard three-meal DCR diet.

Study context

Population
Obese women with polycystic ovary syndrome (PCOS); mean body weight 81.4 kg, mean age 30 years
Participants
90 women
Comparison
14:10 early time-restricted eating (eTRE) alone or with probiotics vs daily calorie restriction (DCR)
  • eTRE + probioticsn = 30
  • eTRE + placebon = 30
  • DCRn = 30reference
Methodological detailsplacebo-controlled, parallel-arm
  • Placebo-controlled
  • Parallel-arm

Primary result

As reported in the abstract

Weight loss · week 8

eTRE + probiotics

−2.2

mean · SD 1.6 · kg

eTRE + placebo

−2.9

mean · SD 2.7 · kg

DCR

−2.5

mean · SD 1.7 · kg

Further findings

OutcomeP value
Metabolic, menstrual and gonadal variables · 8 weeksBetween eTRE + probiotics and DCR · no significant difference between eTRE groups and controlP > 0.05
Metabolic, menstrual and gonadal variables · 8 weeksBetween eTRE + placebo and DCR · no significant difference between eTRE groups and controlP > 0.05
Hormonal and cardiometabolic factors: probiotics added to eTRE · 8 weeksBetween eTRE + probiotics and eTRE + placebo · no benefit of combining probiotics with eTREP > 0.05

Metabolic, menstrual and gonadal variables · 8 weeks

All three regimes reduced body weight, BMI, vascular risk indicators, hirsutism and acne scores

Original publication

The effects of time‐restricted eating alone or in combination with probiotic supplementation in comparison with a calorie‐restricted diet on endocrine and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial. Diabetes Obes Metab. Published 14 August 2024. doi:10.1111/dom.15801

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.